$IIPR
INNOVATIVE INDUSTRIAL PROPERTIES INC

2020 Q1 Form 10-Q Financial Statement

#000110465920058201 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $21.13M $6.823M
YoY Change 209.69% 146.85%
Cost Of Revenue $600.0K $250.0K
YoY Change 140.0% 177.78%
Gross Profit $20.53M $6.580M
YoY Change 212.01% 145.52%
Gross Profit Margin 97.16% 96.44%
Selling, General & Admin $3.350M $1.920M
YoY Change 74.48% 29.73%
% of Gross Profit 16.32% 29.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.907M $1.218M
YoY Change 302.87% 155.88%
% of Gross Profit 23.9% 18.51%
Operating Expenses $8.853M $3.383M
YoY Change 161.69% 65.83%
Operating Profit $12.28M $3.440M
YoY Change 256.89% 375.14%
Interest Expense $1.849M $792.0K
YoY Change 133.46%
% of Operating Profit 15.06% 23.02%
Other Income/Expense, Net
YoY Change
Pretax Income $11.87M $3.640M
YoY Change 226.1% 283.16%
Income Tax
% Of Pretax Income
Net Earnings $11.87M $3.641M
YoY Change 226.06% 285.29%
Net Earnings / Revenue 56.19% 53.36%
Basic Earnings Per Share $0.72 $0.34
Diluted Earnings Per Share $0.72 $0.33
COMMON SHARES
Basic Shares Outstanding 15.78M 9.665M
Diluted Shares Outstanding 15.90M 9.798M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $108.3M $59.20M
YoY Change 82.94% 40.62%
Cash & Equivalents $108.3M $59.22M
Short-Term Investments
Other Short-Term Assets $2.300M
YoY Change 228.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $108.3M $61.50M
YoY Change 76.1% 43.69%
LONG-TERM ASSETS
Property, Plant & Equipment $674.0M $161.2M
YoY Change 318.11% 139.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $272.9M $197.7M
YoY Change 38.04% 304.29%
Other Assets $23.00M
YoY Change
Total Long-Term Assets $972.2M $358.9M
YoY Change 170.87% 209.14%
TOTAL ASSETS
Total Short-Term Assets $108.3M $61.50M
Total Long-Term Assets $972.2M $358.9M
Total Assets $1.080B $420.4M
YoY Change 157.01% 164.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $1.200M
YoY Change -8.33% 100.0%
Accrued Expenses $1.400M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $86.30M $18.80M
YoY Change 359.04% 161.11%
LONG-TERM LIABILITIES
Long-Term Debt $135.2M $133.2M
YoY Change 1.5%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $135.2M $133.2M
YoY Change 1.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $86.30M $18.80M
Total Long-Term Liabilities $135.2M $133.2M
Total Liabilities $221.5M $152.0M
YoY Change 45.69% 2011.56%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $870.5M $265.7M
YoY Change 227.55% 3796228.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $859.0M $268.4M
YoY Change
Total Liabilities & Shareholders Equity $1.080B $420.4M
YoY Change 157.01% 164.58%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $11.87M $3.641M
YoY Change 226.06% 285.29%
Depreciation, Depletion And Amortization $4.907M $1.218M
YoY Change 302.87% 155.88%
Cash From Operating Activities $19.57M $4.603M
YoY Change 325.16% 239.7%
INVESTING ACTIVITIES
Capital Expenditures -$155.2M -$14.20M
YoY Change 992.96%
Acquisitions
YoY Change
Other Investing Activities -$153.1M -$78.00M
YoY Change 96.28% 59.84%
Cash From Investing Activities -$308.3M -$92.29M
YoY Change 234.06% 89.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $317.8M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 302.7M 133.9M
YoY Change 126.14% 72.22%
NET CHANGE
Cash From Operating Activities 19.57M 4.603M
Cash From Investing Activities -308.3M -92.29M
Cash From Financing Activities 302.7M 133.9M
Net Change In Cash 13.98M 46.17M
YoY Change -69.73% 52.3%
FREE CASH FLOW
Cash From Operating Activities $19.57M $4.603M
Capital Expenditures -$155.2M -$14.20M
Free Cash Flow $174.8M $18.80M
YoY Change 829.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001677576
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE INDUSTRIAL PROPERTIES INC
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12637043
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17035674
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-37949
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2963381
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1389 Center Drive, Suite 200
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Park City
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84098
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
12170000
CY2020Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
672876000
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
505861000
CY2020Q1 dei City Area Code
CityAreaCode
858
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
997-3332
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17035674
CY2020Q1 us-gaap Land
Land
51712000
CY2019Q4 us-gaap Land
Land
48652000
CY2020Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
464267000
CY2019Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
382035000
CY2020Q1 us-gaap Tenant Improvements
TenantImprovements
173974000
CY2019Q4 us-gaap Tenant Improvements
TenantImprovements
87344000
CY2020Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
689953000
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
518031000
CY2020Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
17077000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108261000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82244000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
23032000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
35072000
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
272907000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
119595000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1147000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1202000
CY2020Q1 us-gaap Other Assets
OtherAssets
2247000
CY2019Q4 us-gaap Other Assets
OtherAssets
1883000
CY2020Q1 us-gaap Assets
Assets
1080470000
CY2019Q4 us-gaap Assets
Assets
745857000
CY2020Q1 us-gaap Convertible Debt
ConvertibleDebt
135154000
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
134654000
CY2020Q1 iipr Tenant Improvements And Construction Payable
TenantImprovementsAndConstructionPayable
41185000
CY2019Q4 iipr Tenant Improvements And Construction Payable
TenantImprovementsAndConstructionPayable
24968000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1305000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3417000
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
17407000
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
12975000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1204000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1202000
CY2020Q1 iipr Rents Received In Advance And Tenant Security Deposit
RentsReceivedInAdvanceAndTenantSecurityDeposit
25236000
CY2019Q4 iipr Rents Received In Advance And Tenant Security Deposit
RentsReceivedInAdvanceAndTenantSecurityDeposit
20631000
CY2020Q1 us-gaap Liabilities
Liabilities
221491000
CY2019Q4 us-gaap Liabilities
Liabilities
197847000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
14009000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
14009000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17035674
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12637043
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
17000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
870433000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553932000
CY2020Q1 iipr Dividend In Excess Of Earnings
DividendInExcessOfEarnings
-25480000
CY2019Q4 iipr Dividend In Excess Of Earnings
DividendInExcessOfEarnings
-19944000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
858979000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
548010000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1080470000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
745857000
CY2020Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
21130000
CY2019Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
6823000
CY2020Q1 us-gaap Revenues
Revenues
21130000
CY2019Q1 us-gaap Revenues
Revenues
6823000
CY2020Q1 us-gaap Lease Cost
LeaseCost
600000
CY2019Q1 us-gaap Lease Cost
LeaseCost
247000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3346000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1918000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4907000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1218000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
8853000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
3383000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12277000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3440000
CY2020Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1444000
CY2019Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
993000
CY2020Q1 us-gaap Interest Expense
InterestExpense
1849000
CY2019Q1 us-gaap Interest Expense
InterestExpense
792000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11872000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
3641000
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
338000
CY2019Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
338000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11534000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3303000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15784296
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9664775
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15898091
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9797676
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
548010000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11872000
CY2020Q1 iipr Stock Issued During Period Value Sale Of Common Stock
StockIssuedDuringPeriodValueSaleOfCommonStock
317845000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-2166000
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
338000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17070000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
825000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
858979000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
264292000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
3641000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
5569000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-939000
CY2019Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
338000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4412000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
563000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
268376000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11872000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
3641000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4907000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1218000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
825000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
563000
CY2020Q1 iipr Amortization Of Discounts On Short Term Investments
AmortizationOfDiscountsOnShortTermInvestments
-1009000
CY2019Q1 iipr Amortization Of Discounts On Short Term Investments
AmortizationOfDiscountsOnShortTermInvestments
-841000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
501000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
208000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-74000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
93000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
89000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2112000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-744000
CY2020Q1 iipr Increase Decrease In Rents Received In Advance And Tenant Security Deposit
IncreaseDecreaseInRentsReceivedInAdvanceAndTenantSecurityDeposit
4605000
CY2019Q1 iipr Increase Decrease In Rents Received In Advance And Tenant Security Deposit
IncreaseDecreaseInRentsReceivedInAdvanceAndTenantSecurityDeposit
647000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19570000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4603000
CY2020Q1 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
72457000
CY2019Q1 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
7410000
CY2020Q1 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
82698000
CY2019Q1 us-gaap Payments For Tenant Improvements
PaymentsForTenantImprovements
6832000
CY2020Q1 iipr Payment Of Deposits To Escrow For Acquisition
PaymentOfDepositsToEscrowForAcquisition
838000
CY2019Q1 iipr Payment Of Deposits To Escrow For Acquisition
PaymentOfDepositsToEscrowForAcquisition
1601000
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
254803000
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
116945000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
102500000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
40500000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-308296000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92288000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
317845000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2020Q1 iipr Proceeds From Issuance Of Exchange Of Senior Notes
ProceedsFromIssuanceOfExchangeOfSeniorNotes
0
CY2019Q1 iipr Proceeds From Issuance Of Exchange Of Senior Notes
ProceedsFromIssuanceOfExchangeOfSeniorNotes
138557000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12638000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3421000
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2019Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
338000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2166000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
939000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
302703000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133859000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13977000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46174000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117316000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13050000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131293000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59224000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
2695000
CY2020Q1 iipr Accrual For Reimbursements Of Tenant Improvements And Construction Funding
AccrualForReimbursementsOfTenantImprovementsAndConstructionFunding
41185000
CY2019Q1 iipr Accrual For Reimbursements Of Tenant Improvements And Construction Funding
AccrualForReimbursementsOfTenantImprovementsAndConstructionFunding
3201000
CY2020Q1 iipr Accrual For Common And Preferred Stock Dividends Declared
AccrualForCommonAndPreferredStockDividendsDeclared
17408000
CY2019Q1 iipr Accrual For Common And Preferred Stock Dividends Declared
AccrualForCommonAndPreferredStockDividendsDeclared
4750000
CY2020Q1 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
550000
CY2019Q1 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
0
CY2020Q1 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Provision for Impairment. </b>On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the three months ended March 31, 2020 and 2019.</p>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Use of Estimates. </b>The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions.</p>
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 iipr Number Of Property Escrow Account
NumberOfPropertyEscrowAccount
1
CY2020Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2020Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0725
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
22000
CY2020Q1 iipr Percentage Of Current Base Rent
PercentageOfCurrentBaseRent
0.08
CY2020Q1 iipr Purchase Option Price For Real Estate For Land And Buildings
PurchaseOptionPriceForRealEstateForLandAndBuildings
29000000.0
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b>. As of March 31, 2020, we owned 53 properties located in Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania and Virginia. The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates. During the three months ended March 31, 2020, PharmaCann, LLC (“PharmaCann”) leased five properties from us which comprised approximately 24% of rental revenues (including tenant reimbursements). During the three months ended March 31, 2019, PharmaCann leased two properties from us which comprised approximately 31% of rental revenues (including tenant reimbursements). In addition, during the three months ended March 31, 2020, Ascend Wellness Holdings, LLC’s leases at certain of our properties located in Illinois and Michigan accounted for approximately 9% of our rental revenues (including tenant reimbursements).</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">At March 31, 2020, we had a property in each of Florida, Illinois, Michigan, and Pennsylvania that individually accounted for approximately 5% of our net real estate held for investment. At December 31, 2019, one of our properties in New York accounted for approximately 6% of our net real estate held for investment.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">We have deposited cash with a financial institution that is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of March 31, 2020, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.</p>
CY2020Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;"><b style="font-weight:bold;">Reclassifications.</b> Certain prior period amounts have been reclassified for consistency with the current period presentation. The reclassifications included the combined presentation of tenant reimbursements with rental revenue on the condensed consolidated statements of income for the three months ended March 31, 2019, the presentation of dividends in excess of earnings separate from additional paid-in-capital, on the condensed consolidated statements of stockholders’ equity for the three months ended March 31, 2019 to conform to the current period presentation and the reclassification between net cash provided by operating activities and net cash used in investing activities in the condensed consolidated statements of cash flows for the three months ended March 31, 2019 to conform to the current period presentation. These reclassifications had no effect on the reported condensed consolidated results of operations.</p>
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q1 us-gaap Net Rentable Area
NetRentableArea
765000
CY2020Q1 iipr Real Estate Investment Purchase Price
RealEstateInvestmentPurchasePrice
72840000
CY2020Q1 iipr Real Estate Investments Transaction Costs
RealEstateInvestmentsTransactionCosts
167000
CY2020Q1 us-gaap Real Estate Investments
RealEstateInvestments
73007000
CY2020Q1 iipr Real Estate Property Cost
RealEstatePropertyCost
98900000
CY2020Q1 iipr Additional Purchase Price Of Building Improvements
AdditionalPurchasePriceOfBuildingImprovements
82700000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
76071000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
110294000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
112383000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
115775000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
119282000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
1615224000
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
2149029000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
5800000
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0465
CY2020Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
5200000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5000000.0
CY2020Q1 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
200000
CY2020Q1 iipr Cash Coupon
CashCoupon
1348000
CY2019Q1 iipr Cash Coupon
CashCoupon
584000
CY2020Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
268000
CY2019Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
111000
CY2020Q1 iipr Interest Expense Distribution To Participating Securities
InterestExpenseDistributionToParticipatingSecurities
233000
CY2019Q1 iipr Interest Expense Distribution To Participating Securities
InterestExpenseDistributionToParticipatingSecurities
97000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1849000
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
792000
CY2020Q1 iipr Convertible Senior Notes Debt
ConvertibleSeniorNotesDebt
143749000
CY2019Q4 iipr Convertible Senior Notes Debt
ConvertibleSeniorNotesDebt
143750000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4610000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4878000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3985000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4218000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
135154000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
134654000
CY2020Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
225000
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1600000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
11872000
us-gaap Net Income Loss
NetIncomeLoss
3641000
CY2020Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
338000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
338000
CY2020Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
115000
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
64000
CY2020Q1 iipr Net Income Loss Used To Compute Common Stockholders
NetIncomeLossUsedToComputeCommonStockholders
11419000
iipr Net Income Loss Used To Compute Common Stockholders
NetIncomeLossUsedToComputeCommonStockholders
3239000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15784296
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9664775
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15898091
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9797676
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
272907000
CY2020Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
274399000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
119595000
CY2019Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
119673000
CY2020Q1 us-gaap Convertible Debt
ConvertibleDebt
135154000
CY2020Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
179801000
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
134654000
CY2019Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
185558000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
139546
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
37.03
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
15918
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
75.11
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
45975
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
37.01
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
28552
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
19.72
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
80937
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
50.64
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3400000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2020Q1 iipr Tenant Improvement Payable
TenantImprovementPayable
89000000.0
CY2020Q1 iipr Tenant Improvement May Canceled
TenantImprovementMayCanceled
45900000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
152000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
235000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
242000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
249000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
256000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
88000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1222000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1204000

Files In Submission

Name View Source Status
0001104659-20-058201-index-headers.html Edgar Link pending
0001104659-20-058201-index.html Edgar Link pending
0001104659-20-058201.txt Edgar Link pending
0001104659-20-058201-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iipr-20200331.xsd Edgar Link pending
iipr-20200331x10q.htm Edgar Link pending
iipr-20200331x10q_htm.xml Edgar Link completed
iipr-20200331xex10d5.htm Edgar Link pending
iipr-20200331xex31d1.htm Edgar Link pending
iipr-20200331xex31d2.htm Edgar Link pending
iipr-20200331xex32d1.htm Edgar Link pending
iipr-20200331_cal.xml Edgar Link unprocessable
iipr-20200331_def.xml Edgar Link unprocessable
iipr-20200331_lab.xml Edgar Link unprocessable
iipr-20200331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending